ABOUT ELITE
PRODUCTS
PIPELINE
- Generic
- Branded
TECHNOLOGY
INVESTOR RELATIONS

HOME | CAREERS | CONTACT | NEWS |

Skip to content

About Elite
Products
Pipeline
- Generic
- Branded
Technology
Investor Relations

Press Releases

Select:

Feb 10, 2014 lite Pharmaceuticals, Inc. to Host Third Quarter Business Update Call on February 18, 2014

Nov 14, 2013 Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2014

Aug 12, 2013 Elite Pharmaceuticals, Inc. Hires Industry Veteran Doug Plassche as Executive Vice President of Operations

Aug 05, 2013 Elite Pharmaceuticals, Inc. Appoints Nasrat Hakim as President and Chief Executive Officer

Jun 21, 2013 Elite Pharmaceuticals, Inc. Reports Financial Results for the

Jun 19, 2013 Elite Pharmaceuticals, Inc. Announces 2013 Fiscal Year End Conference Call on Monday, June 24, 2013

Jun 10, 2013 Elite Laboratories Files Citizen Petition With The Fda On Brompheniramine Maleate And Pseudoephedrine Hcl Extended Release

May 21, 2013 Elite Pharmaceuticals Announces Change In Executive Leadership

Apr 23, 2013 Elite Pharmaceuticals Awarded Second U.S. Patent For Abuse Resistant Drug Formulation

Apr 22, 2013 Elite Pharmaceuticals, Inc. Secures $10 Million Funding Commitment From Lincoln Park Capital Fund, Llc

13 14 15 16 17 18 19 20 21 22 23

<< < > >>

Site Map | Privacy | Terms Of Use

Copyright © Elite Pharmaceuticals Inc. | All Rights Reserved.

ART™: Abuse-Resistant Technology for a safer healthier you.

Resize Viewer - Reduce

Resize Viewer - Expand